Messenger RNA for peroxisome proliferator-activated receptor ␥ (PPAR␥) has been found in granulosa cells, and its expression decreases after the LH surge. We determined which developmental stage of ovarian follicle expresses mRNA for PPAR␥ and evaluated the impact of PPAR␥ agonists on steroidogenesis. Ovaries were collected from immature eCG/hCG-treated rats at 0 (no eCG), 24, and 48 h post-eCG and 4 and 24 h post-hCG. Ovarian tissue was serially sectioned and processed for in situ hybridization to localize mRNA corresponding to PPAR␥, aromatase, and the LH receptor, and P450 side chain cleavage (P450 SCC ) and to determine whether apoptotic cells were present. During follicular development, there was no correlation between the expression of mRNAs for PPAR␥ and aromatase or the presence of apoptotic cells, but a general inverse correlation was observed between the expression of PPAR␥ mRNA and LH receptor mRNA. At 4 h post-hCG, follicles expressing P450 SCC mRNA had lost expression of PPAR␥ mRNA. This inverse pattern of expression between PPAR␥ and P450 SCC mRNAs was also observed 24 h post-hCG, with developing luteal tissue expressing high levels of P450 SCC mRNA but little or no PPAR␥ mRNA. To determine the impact of PPAR␥ on steroidogenesis, granulosa cells were collected from ovaries 24 h post-eCG and cultured alone, with FSH alone, or with FSH in combination with the PPAR␥ agonists ciglitazone or 15-deoxy-⌬ 12,14 -prostaglandin J 2 (PGJ 2 ). Treatment of granulosa cells with PGJ 2 stimulated basal progesterone secretion, whereas ciglitazone or PGJ 2 had no significant effect on FSH-stimulated steroid production. These findings suggest that 1) PPAR␥ may regulate genes involved with follicular differentiation and 2) the decline in PPAR␥ in response to LH is important for ovulation and/or luteinization.
INTRODUCTION
The ovarian follicle is comprised of two steroidogenic cell types, granulosa cells and theca cells. These cells work cooperatively during the follicular phase to produce estradiol. The synthesis of estradiol involves androgens produced by the theca diffusing across the basement membrane into the granulosa cell compartment, where they are con-1 This work was supported by grants NIH P20 RR 15592 (to T.E.C. and C.M.K.) and NIH HD40842 (to C.M.K.). verted into estrogen by aromatase. In response to the LH surge, granulosa and theca cells differentiate into large and small cells of the corpus luteum, respectively. Accompanying this cellular differentiation is a shift in steroid production from estradiol to progesterone. Although there is a vast amount of information about the changes that occur during the final maturation of follicular cells and the periovulatory shift in steroid production, the mechanisms regulating these changes are not completely understood.
The peroxisome proliferator-activated receptors (PPARs) are a family of nuclear hormone receptors that play a role in cellular differentiation and function. Three distinct PPAR family members have been identified: PPAR␣, PPAR␦, and PPAR␥. These transcription factors regulate gene expression by forming heterodimers with the 9-cis-retinoic acid receptor and binding to a PPAR response element (PPRE) in the promoter region of target genes. The presence of a PPRE in the cyclooxygenase-2 gene, whose expression is regulated by PPARs [1] [2] [3] , and reports that PPAR activators can influence the expression and activity of aromatase [4] [5] [6] [7] [8] suggest a potential role for this class of transcription factors in ovarian steroidogenesis and cellular differentiation. Support for the hypothesis that the PPARs impact ovarian function comes from experiments in which PPARs have been identified in ovarian tissue from humans [9] , cattle [10, 11] , pigs [12] , rats [13] [14] [15] , and mice [16] . Furthermore, activators of PPAR␥ can regulate steroid production by cultured granulosa [4, 14, 17] , theca [12] , and luteal [10] cells. Recently, Cui et al. [16] reported that one-third of mice lacking expression of PPAR␥ in granulosa cells were infertile and the remaining two-thirds had reduced fertility. These authors speculated that the reduction in fertility was the result of inadequate ovarian function [16] . These data provide strong support for the fundamental role of PPARs in ovarian physiology.
In a previous study, we demonstrated that the expression of mRNA for PPAR␥ was restricted primarily to granulosa cells of developing follicles in the rat and that expression declined in response to the LH surge [14] . Not all follicles expressed PPAR␥ at the same level nor did all follicles lose expression after the gonadotropin surge. These findings led us to question whether the differential pattern of expression of mRNA for PPAR␥ seen between follicles reflected the ability of granulosa cells to produce estradiol and whether the decline in the expression of mRNA for PPAR␥ after the LH surge is coupled with an increase in the production of progesterone. To begin answering these questions, the localization and expression of mRNA for PPAR␥, P450 side chain cleavage (P450 SCC ), aromatase, and the LH receptor and the presence of apoptotic cells were identified within follicles from serial sections of rat ovarian tissue collected during follicular development and the periovulatory period. The potential of PPAR␥ to influence gonadotropin-stimulated steroid production was also investigated using granulosa cells cultured in the presence of FSH with and without the PPAR␥ agonists 15-deoxy-⌬ 12,14 -prostaglandin J 2 (PGJ 2 ) and ciglitazone [18, 19] .
MATERIALS AND METHODS

Materials
Unless otherwise noted, all chemicals were purchased from Sigma Chemical Company (St. Louis, MO) or Fisher Scientific (Pittsburgh, PA). OCT embedding compound was obtained from VWR Scientific (Atlanta, GA). Ciglitazone was purchased from Biomol (Plymouth Meeting, PA), and PGJ 2 from Cayman Chemical Co. (Ann Arbor, MI).
Animals
All animal procedures were approved by our Institutional Animal Care and Use Committee. Female Sprague-Dawley rats (Harlan Sprague-Dawley, Indianapolis, IN) were injected s.c. with 10 IU eCG (provided by Dr. A.F. Parlow, National Hormone & Peptide Program, NIDDK) on Day 23 of age (n ϭ 15) to initiate follicular development. Ovaries were collected from a subset of these animals at 0 (no eCG), 24 , and 48 h post-eCG (n ϭ 3 rats/time point). The remaining animals received 10 IU of hCG 48 h post-eCG to stimulate ovulation and luteal development. Ovaries were collected from this group of animals 4 and 24 h post-hCG (n ϭ 3 rats/ time point). All ovaries were placed in OCT and stored at Ϫ70ЊC.
To investigate the role of PPAR␥ in gonadotropin-stimulated steroidogenesis, granulosa cells were collected from eCG-primed immature rats. On Day 23 of age, female rats received 10 IU eCG s.c.; 24 h later, granulosa cells were collected as described previously [20] .
In Situ Hybridization
Ovarian tissues were serially sectioned at 10 m and mounted on ProbeOn Plus slides (Fisher). Tissue sections were processed for in situ hybridization as described previously [14] . Plasmids containing cDNAs for P450 SCC , aromatase (generously provided by Dr. J.S. Richards, Baylor College of Medicine, Houston, TX), the LH receptor (a gift from Dr. O.-K. Park-Sarge, University of Kentucky, Lexington, KY), and PPAR␥ (kindly provided by Dr. Walter Wahli, Université de Lausanne, Lausanne, Switzerland) were linearized using the appropriate restriction enzymes. Radiolabeled sense and antisense riboprobes were synthesized using a MAXISCRIPT kit (Ambion, Austin, TX) and [␣- 35 S]UTP (10 Ci/ml; ICN, Irvine, CA). Tissues were hybridized with radiolabeled probe (10 6 cpm) in 50 l hybridization buffer at 50ЊC for 15-18 h. Slides were dipped in Kodak NTB2 emulsion and stored at 4ЊC for 1-4 wk before being developed.
Cell Culture
Granulosa cells were pooled, and 10 6 cells/ml were cultured in Dulbecco modified Eagle medium:Hams F-12 medium containing 1% BSA, 0.01% pyruvic acid, 0.22% bicarbonate, and insulin/transferrin/selenite at 37ЊC in an atmosphere of 5% CO 2 :95% air. Cultured cells were treated in duplicate as follows (n ϭ 5 independent experiments): control (dimethyl sulfoxide), FSH (50 ng/ml; provided by Dr. A.F. Parlow), ciglitazone (50 M), PGJ 2 (50 M), FSH ϩ ciglitazone, and FSH ϩ PGJ 2 . Treatments were added to the cells at the time of plating. Twenty-four hours after the initiation of culture, media were collected to measure the concentrations of estradiol and progesterone by RIA.
Radioimmunoassay
Concentrations of estradiol and progesterone were determined in conditioned culture media using Coat-A-Count tubes (Diagnostic Products Co., Los Angeles, CA), which are direct solid-phase 125 I RIA kits. Assay sensitivity is 50 pg/ml and 0.03 ng/ml for estradiol and progesterone, respectively. For measuring concentrations of each steroid, all samples were analyzed together in one assay.
Detection of Apoptotic Cells
Apoptotic cells were identified in serial sections of frozen ovarian tissue using ApoAlert (Clontech, Palo Alto, CA) as described previously [14] .
Statistical Analysis
Concentrations of estradiol and progesterone in conditioned culture media were analyzed using a one-way ANOVA. Results were considered significant at P Ͻ 0.01. Post hoc comparisons were made using the Tukey HSD test.
RESULTS
Early in follicular development (0 h post-eCG), the majority of follicles contained granulosa cells expressing mRNA for PPAR␥ (Fig. 1a) . As reported previously [14] , some follicles contained granulosa cells that had relatively high levels of expression for PPAR␥ mRNA compared with other follicles of similar size. The granulosa cells in a few large antral follicles expressed mRNA for aromatase (Fig.  1c) , but the expression of mRNA for the LH receptor was limited to the theca and stroma (Fig. 1b) . At the early stages of follicular development, expression of mRNA for PPAR␥ was not correlated with localization of mRNA for aromatase. Similarly, there was no correlation observed between the expression of mRNA for PPAR␥ and the presence or absence of apoptotic cells (Fig. 1d) .
By 24 h post-eCG, mRNA for the LH receptor was seen in the theca of most follicles and in the granulosa cells of maturing follicles (Fig. 1g) . Granulosa cells in developing follicles still expressed mRNA for PPAR␥ (Fig. 1f) . The granulosa cells in larger antral follicles that expressed high levels of mRNA for PPAR␥ tended to lack expression of mRNA for the LH receptor, whereas follicles containing granulosa cells with relatively low levels of PPAR␥ mRNA expressed high levels of LH receptor mRNA (Fig. 1, f and  g, arrows) . The expression of mRNA for aromatase also tended to be higher in granulosa cells expressing LH receptor mRNA relative to the expression in granulosa cells with little or no LH receptor mRNA (Fig. 1, h and g, arrows) .
The same patterns of expression of mRNA for PPAR␥, aromatase, and the LH receptor continued during the later phases of follicular development (48 h post-eCG, no hCG; Fig. 2, a-d) . The expression of mRNA for P450 SCC at this time was seen primarily in the theca and stroma (Fig. 2b) . However, by 4 h post-hCG, there was a differential pattern of expression observed between P450 SCC and PPAR␥, with a loss of PPAR␥ mRNA in those follicles where granulosa cells expressed P450 SCC mRNA (Figs. 2, f and g, and 3 , a and c). The expression of P450 SCC mRNA in granulosa cells correlated with the expression of LH receptor mRNA (Figs. 2, g and i, and 3, c and e) . At this stage of the periovulatory period, the expression of mRNA for P450 SCC and PPAR␥ appeared to be in transition. Granulosa cells in a follicle losing expression of mRNA for PPAR␥ began to express mRNA for P450 SCC (Fig. 2, f and g, arrowhead) . This transition in expression can also been seen with aromatase mRNA. In some large antral follicles that maintained expression of mRNA for aromatase 4 h post-hCG (including the follicle marked with an arrowhead in Fig. 2 , f and g), expression was not uniform throughout the granulosa cell layers (Fig. 2h, arrowhead) .
The differential pattern of expression between mRNA for SCC and PPAR␥ was also seen 24 h post-hCG. The forming luteal structures expressed high levels of mRNA for SCC whereas the expression of mRNA for PPAR␥ was low to undetectable (Fig. 2, k and l) . One follicle with granulosa cells expressing mRNA for PPAR␥ only expressed mRNA for P450 SCC in the theca (Fig. 2, k and l,  arrows) . The granulosa cells of this same follicle expressed mRNA for aromatase (Fig. 2m), indicating that it was a FIG. 1. Localization of mRNAs for PPAR␥  (a and f) , the LH receptor (b and g), and aromatase (c and h) and the detection of apoptotic cells (d and i) in serial sections of ovarian tissue collected from rats at 0 h (a-e) and 24 h (f-j) post-eCG. Brightfield images (e and j) are provided for serial tissue sections (a and f, respectively). Tenmicrometer tissue sections were hybridized with 35 S-labeled antisense riboprobes. Symbols identify a single follicle throughout the serial sections. Arrows indicate follicles with different levels of expression for PPAR␥ mRNA, LH receptor mRNA, and aromatase mRNA. ϫ40.
healthy (Fig. 2o) , growing follicle. As expected, the expression of mRNA for the LH receptor was low at this stage of luteal development (Fig. 2n) .
At all time points examined during the periovulatory period, there was no correlation observed between the expression of mRNA for PPAR␥ and the presence or absence of apoptotic cells (Fig. 2) . Additionally, there was no labeling observed at any time point investigated in tissue sections hybridized with sense riboprobes for PPAR␥, aromatase, the LH receptor, or P450 SCC (representative images from tissue collected 4 h post-hCG shown in Fig. 3) .
To determine whether activators of PPAR␥ modified go- nadotropin-stimulated steroid production, granulosa cells were cultured with FSH and agonists of PPAR␥, PGJ 2 or ciglitazone. Cells treated with FSH secreted Ͼ2 times more estradiol (FSH: 3188 Ϯ 593 pg/ml; control: 1417 Ϯ 531 pg/ml; Fig. 4A ) and 300 times more progesterone (FSH: 224 Ϯ 45 ng/ml; control: 0.66 Ϯ 0.24 ng/ml; P Ͻ 0.01; Fig. 4B ) than control cultures. Treatment with PGJ 2 stimulated basal progesterone production (P Ͻ 0.01; Fig. 4B ) but not estradiol production. Neither PPAR␥ agonist significantly influenced FSH-stimulated steroidogenesis, although there was a trend toward inhibition of gonadotropinstimulated steroid production by PGJ 2 (P ϭ 0.15 for estradiol, P ϭ 0.14 for progesterone).
DISCUSSION
We have previously shown that mRNA for PPAR␥ is restricted primarily to granulosa cells of developing follicles and that expression decreases in response to the LH surge [14] . PPAR␥ was first identified as an adipocyte differentiation factor (reviewed in [21, 22] ). It also plays a role in the cell cycle and apoptosis (reviewed in [18, 23, 24] ) and in steroidogenesis [4, 10, 12, 14, 17] . Because these processes occur in granulosa cells during the course of follicular development and/or luteinization, the current studies were designed to begin investigation of the role(s) of PPAR␥ in the ovary by characterizing the follicles expressing mRNA for PPAR␥. 35 S-labeled antisense (a, c, e, and g) and sense (b, d, f, and h) riboprobes corresponding to mRNAs for PPAR␥ (a and b), P450 SCC (c and d), the LH receptor (e and f ), and aromatase (g and h). ϫ100.
OVARIAN PPAR␥ AND P450 SIDE CHAIN CLEAVAGE
The expression of mRNA for PPAR␥ in granulosa cells was compared with the expression of markers for follicular development, differentiation, and subsequent luteinization. During follicular development, mRNA for aromatase is restricted to granulosa cells and its expression increases as follicles differentiate into preovulatory follicles [25, 26] . Messenger RNA for the LH receptor is expressed in the theca from very early in follicular development, but its expression in granulosa cells does not occur until follicles grow from small antral to preovulatory in size [27] [28] [29] [30] . In response to an LH surge, the expression of mRNAs for the LH receptor and aromatase is downregulated [27] [28] [29] [30] , whereas the expression of mRNA for P450 SCC is stimulated as the follicle becomes luteinized [31] [32] [33] [34] . Therefore, mRNAs for aromatase, the LH receptor, and P450 SCC were used to identify developing follicles with granulosa cells that were in the later stages of development and capable of responding to an LH surge and those follicles that had responded to the LH surge and were in the early stages of luteinization.
The results reported here illustrate that the expression of mRNA for PPAR␥ is inversely related to the expression of mRNA for P450 SCC . As follicles matured, those follicles containing granulosa cells expressing high levels of mRNA for the LH receptor tended to express lower relative levels of mRNA for PPAR␥. These observations suggest that those follicles capable of responding to the LH surge have a reduction in expression of mRNA for PPAR␥ and that a decline in this transcription factor may be important for the processes of ovulation and luteinization. This conclusion is supported by the lack of expression of mRNA for PPAR␥ during early luteal development. However, in the naturally FIG. 4 . Concentrations (means Ϯ SEM) of estradiol (pg/ml) (A) and progesterone (ng/ ml) (B) in conditioned culture media. Granulosa cells were cultured for 24 h (five independent experiments in duplicate). Bars with different superscripts are significantly different (P Ͻ 0.01). C, Control; Cig, ciglitazone; PGJ, PGJ 2 .
cycling animal, mRNA for PPAR␥ is expressed in luteal tissue and at relatively high levels in luteal tissue remaining from previous cycles [35] . These data and the findings reported here indicate that PPAR␥ plays a role in luteal function, but it may be more involved in luteal maintenance and/or regression than in development.
The lack of correlation of mRNA expression for aromatase and PPAR␥ either before or after the LH surge suggests that PPAR␥ does not play a critical role in the expression of this P450 enzyme in the rat ovary. However, this finding does not rule out the ability of PPAR␥ to influence aromatase expression or subsequent activity. It has been shown that activators of PPAR␥ inhibited the expression and activity of aromatase in human granulosa-lutein cells [4] , malignant granulosa cells [6] , and breast adipose tissue [5, 7] . One mechanism by which activators of PPAR␥ inhibit aromatase in human breast adipose is via an indirect effect on promoter II of aromatase [7] . Ovarian expression of aromatase is under the regulation of promoter II [36] . Thus, the possibility exists that PPAR␥ may regulate the activity of aromatase by interactions with the promoter during the latter stages of follicular development.
In previous studies, activators of PPAR␥ influenced steroid production by cultured granulosa, luteal, and theca cells [10, 12, 14] . Because the expression of mRNA for PPAR␥ is high in granulosa cells during folliculogenesis, we investigated the ability of PPAR␥ activators to modify FSH-stimulated steroid production during the early stages of follicular development. As expected, cultured granulosa cells responded to FSH with increased steroid production. The addition of PGJ 2 or ciglitazone to granulosa cells in culture had no effect on FSH-stimulated estradiol or progesterone secretion. However, treatment with PGJ 2 significantly increased basal secretion of progesterone. Because ciglitazone did not stimulate basal progesterone production, the increase in progesterone secretion may be a direct effect of PGJ 2 on granulosa cells independent of PPAR␥ activation. This conclusion is supported by the fact that prostenoids can stimulate follicular steroidogenesis [37, 38] . Previously, we reported that activators of PPAR␥ stimulated the secretion of both progesterone and estradiol from cultured rat granulosa cells collected during the latter stages of follicular development [14] . Although the changes reported in the current study were not significant, the trends in estradiol and progesterone production paralleled the findings in the previous study. The difference in magnitude of response between the previous study and the current study is most likely the result of using granulosa cells at different stages of development. In the current study, granulosa cells were collected from developing follicles 24 h post-eCG, whereas in the previous study [14] cultured granulosa cells were collected from maturing follicles 48 h post-eCG. More follicles expressed mRNA for aromatase and the LH receptor at 48 h post-eCG than at 24 h post-eCG ( Figs. 1 and  2 ). These changes are associated with a more advanced stage of follicular maturation. Because levels of mRNA for PPAR␥ were high at both time points, the influence of PPAR␥ activation on steroid production most likely reflects the cellular environment and how PPAR␥ interacts with cellular events particular to those stages of development. Thus, the response of rat granulosa cells to PPAR␥ agonists may be dependent upon the stage of follicular differentiation.
Ovarian follicles undergo atresia by a process of programmed cell death called apoptosis [39] . In the current study, exogenous gonadotropins were administered to immature rats to increase the number of developing follicles. In this model, the presence or absence of apoptotic cells in follicles was not correlated with high, low, or loss of expression of mRNA for PPAR␥. Hence, although PPAR␥ is involved in apoptosis in other cell systems, its expression pattern observed in the current study indicates that it may not play a major role in follicular atresia in this animal model.
The findings reported here show that the expression of mRNA for PPAR␥ is inversely correlated with the expression of mRNA for P450 SCC . Because the expression of PPAR␥ mRNA is high in the granulosa cells of developing follicles, PPAR␥ may be responsible for regulating the expression of genes involved with growth, development, and/ or differentiation of the follicle. Studies are underway to further investigate the role of PPAR␥ in the ovary, which will allow us to better understand how this transcription factor influences ovarian function.
